65 related articles for article (PubMed ID: 29463522)
1. Question 1: Is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg?
Wilkins AL; Steer AC; Cranswick N; Gwee A
Arch Dis Child; 2018 May; 103(5):514-519. PubMed ID: 29463522
[No Abstract] [Full Text] [Related]
2. Persistence of itching in patients after scabies therapy: What to do?
Fidanzi C; Manzo Margiotta F; Bevilacqua M; D'Erme AM; Bagnoni G; Dini V; Janowska A
Travel Med Infect Dis; 2023; 56():102652. PubMed ID: 37832709
[No Abstract] [Full Text] [Related]
3. Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19.
Temple C; Hoang R; Hendrickson RG
N Engl J Med; 2021 Dec; 385(23):2197-2198. PubMed ID: 34670041
[No Abstract] [Full Text] [Related]
4. Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study.
Levy M; Martin L; Bursztejn AC; Chiaverini C; Miquel J; Mahé E; Maruani A; Boralevi F;
Br J Dermatol; 2020 Apr; 182(4):1003-1006. PubMed ID: 31344258
[TBL] [Abstract][Full Text] [Related]
5. Oral ivermectin for infants and children under 15 kg appears to be a safe and effective treatment for scabies.
Morris-Jones R
Br J Dermatol; 2020 Apr; 182(4):835-836. PubMed ID: 31885077
[No Abstract] [Full Text] [Related]
6. Serious Ivermectin Toxicity and Human
Baudou E; Lespine A; Durrieu G; André F; Gandia P; Durand C; Cunat S
N Engl J Med; 2020 Aug; 383(8):787-789. PubMed ID: 32813957
[No Abstract] [Full Text] [Related]
7. Ivermectin and permethrin for treating scabies.
Rosumeck S; Nast A; Dressler C
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD012994. PubMed ID: 29608022
[TBL] [Abstract][Full Text] [Related]
8. Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study).
Lake SJ; Phelan SL; Engelman D; Sokana O; Nasi T; Boara D; Gorae C; Schuster T; Grobler AC; Osti MH; Andrews R; Marks M; Whitfeld MJ; Romani L; Kaldor J; Steer A
BMJ Open; 2020 Aug; 10(8):e037305. PubMed ID: 32868360
[TBL] [Abstract][Full Text] [Related]
9. Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis.
Nicolas P; Maia MF; Bassat Q; Kobylinski KC; Monteiro W; Rabinovich NR; Menéndez C; Bardají A; Chaccour C
Lancet Glob Health; 2020 Jan; 8(1):e92-e100. PubMed ID: 31839144
[TBL] [Abstract][Full Text] [Related]
10. Ivermectin use in children below 15 kg: potential benefits for onchocerciasis and scabies elimination programmes.
Colebunders R; Wafula ST; Hotterbeekx A; Siewe-Fodjo JN
Br J Dermatol; 2020 Apr; 182(4):1064. PubMed ID: 31693749
[No Abstract] [Full Text] [Related]
11. Paediatrics: how to manage scabies.
Thompson R; Westbury S; Slape D
Drugs Context; 2021; 10():. PubMed ID: 33828606
[TBL] [Abstract][Full Text] [Related]
12. The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use.
Pfarr KM; Krome AK; Al-Obaidi I; Batchelor H; Vaillant M; Hoerauf A; Opoku NO; Kuesel AC
Parasit Vectors; 2023 Oct; 16(1):394. PubMed ID: 37907954
[TBL] [Abstract][Full Text] [Related]
13. Comparison of topical benzyl benzoate vs. oral ivermectin in treating scabies: A randomized study.
Meyersburg D; Welponer T; Kaiser A; Selhofer S; Tatarski R; Handisurya A; Bauer JW
J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):160-165. PubMed ID: 36097258
[TBL] [Abstract][Full Text] [Related]
14. High infection rates for onchocerciasis and soil-transmitted helminthiasis in children under five not receiving preventive chemotherapy: a bottleneck to elimination.
Nana-Djeunga HC; Djune-Yemeli L; Domche A; Donfo-Azafack C; Efon-Ekangouo A; Lenou-Nanga C; Nzune-Toche N; Balog YA; Bopda JG; Mbickmen-Tchana S; Velavan TP; Penlap-Beng V; Ntoumi F; Kamgno J
Infect Dis Poverty; 2022 Apr; 11(1):47. PubMed ID: 35484570
[TBL] [Abstract][Full Text] [Related]
15. Broadening the range of use cases for ivermectin - a review of the evidence.
Kositz C; Bradley J; Hutchins H; Last A; D'Alessandro U; Marks M
Trans R Soc Trop Med Hyg; 2022 Mar; 116(3):201-212. PubMed ID: 34323283
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?
Jittamala P; Monteiro W; Smit MR; Pedrique B; Specht S; Chaccour CJ; Dard C; Del Giudice P; Khieu V; Maruani A; Failoc-Rojas VE; Sáez-de-Ocariz M; Soriano-Arandes A; Piquero-Casals J; Faisant A; Brenier-Pinchart MP; Wimmersberger D; Coulibaly JT; Keiser J; Boralevi F; Sokana O; Marks M; Engelman D; Romani L; Steer AC; von Seidlein L; White NJ; Harriss E; Stepniewska K; Humphreys GS; Kennon K; Guerin PJ; Kobylinski KC
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009144. PubMed ID: 33730099
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous Myiasis Caused by
Sangmala S; Aiempanakit K; Khantee P; Pengsakul T
Case Rep Dermatol; 2020; 12(3):249-254. PubMed ID: 33362512
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of ivermectin for the treatment of scabies in Indigenous Australian children.
Gwee A; Duffull S; Zhu X; Tong SYC; Cranswick N; McWhinney B; Ungerer J; Francis J; Steer AC
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008886. PubMed ID: 33284799
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
